Colistimethate Sodium Injection IP 1 Million IU – Lisobil 1 Miu Injection

Lisobil 1 Miu Injection – The Last Line of Defense Against Multidrug-Resistant Infections .

Lisobil 1 Miu Injection – The Combination of Colistimethate Sodium Injection IP 1 Million IU is an antibiotic It kills bacteria by destroying the bacterial cell membrane and which is used in the treatment of life-threatening infections caused by multidrug-resistant Gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter baumannii, and is converted in the body to colistin, which binds to the bacterial cell membrane phospholipids, disrupting its integrity. This causes leakage of cell contents and ultimately leads to bacterial cell death. It is bactericidal in action

Key Benefits of Colistimethate Sodium Injection IP 1 Million IU – Lisobil 1 Miu Injection
Broad-Spectrum Activity Against Gram-Negative Pathogens: To targets pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and other tough hospital-acquired organisms.
Bactericidal Mechanism: For fast acting threatening conditions which Acts by disrupting bacterial cell membranes, leading to rapid bacterial cell death.
Reserved Use for High-Impact Therapy: To Prevent antibiotic overuse and resistance spread through restricted, targeted use guided by infectious disease specialists.

Recommended By Specialists:
Infectious Disease Specialists: To mainly prescribe the combinations Lead in managing multidrug-resistant (MDR) bacterial infections.
Pulmonologists: To treat pneumonia, especially hospital-acquired which is used via nebulization in conditions like cystic fibrosis or chronic pulmonary infections.
Internal Medicine Physicians: For managing complicated infections in inpatient care, particularly when culture sensitivity reports support its use.

INDICATIONS:
Complicated Urinary Tract Infections (UTIs)
Bloodstream Infections (Bacteremia)
Acute Respiratory Distress Syndrome (ARDS)